Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729701 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation
A Phase 2 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT02729701 is a Phase 2 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT02729701, a Phase 2 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether daily use of Duavee® is accepted and tolerated by peri- and post-menopausal women at moderate risk for development of breast cancer.
Interventions
- DRUG Duavee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729701
The ClinicalTrials.gov registry entry for NCT02729701 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Duavee is the first listed.
NCT02729701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02729701 about?
NCT02729701 is a clinical study titled "Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation". The purpose of this study is to learn whether daily use of Duavee® is accepted and tolerated by peri- and post-menopausal women at moderate risk for development of breast cancer.
What is the current status of trial NCT02729701?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2016-05. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02729701?
The interventions under investigation include: Duavee (DRUG).
Who is sponsoring clinical trial NCT02729701?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.